STOCK TITAN

Intricon to Announce 2020 Fourth Quarter and Full Year Results on Thursday, February 25, 2021

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Intricon Corporation (NASDAQ: IIN) announced its intent to release the 2020 fourth quarter and full year results on February 25, 2021, after market close. The management team will hold a conference call at 4:00 p.m. CT/5:00 p.m. ET on the same day, accessible via a designated call-in number. A live webcast will also be available on Intricon's website. As a Joint Development Manufacturer, Intricon focuses on enhancing micro-medical technology, partnering closely with customers throughout the development process to improve clinical outcomes.

Positive
  • None.
Negative
  • None.

ARDEN HILLS, Minn., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering and manufacturing miniature interventional, implantable and body-worn medical devices, today announced that it will release its 2020 fourth quarter and full year results on Thursday, February 25, 2021, after market close.

Following the release, Intricon’s management team will host a conference call on the same day, beginning at 4:00 p.m. CT/5:00 p.m. ET. Investors interested in listening to the conference call may do so by dialing (866) 795-7248 for domestic callers or (470) 495-9160 for international callers, using conference ID: 5468087. A live and archived webcast will be available on the “Investors” sections of the company’s website at: www.intricon.com.

About Intricon Corporation
Intricon is a Joint Development Manufacturer that integrates components and assemblies to advance micro-medical technology across a range of device platforms for global customers. Intricon approaches each engagement with an all-in commitment, working with customers every step of the way- from the earliest idea stages to ongoing production - in order to advance program performance and deliver results. With a focus on key device platforms, Intricon helps advance clinical outcomes by always looking ahead with proactive support and resources through integration of its core competencies. Intricon has facilities in the United States, Asia and Europe. The company's common stock trades under the symbol "IIN" on the NASDAQ Global Market.

Investor Relations Contact:
Leigh Salvo
(415) 937-5404
investorrelations@intricon.com


FAQ

When will Intricon Corporation announce its 2020 financial results?

Intricon Corporation will release its 2020 fourth quarter and full year results on February 25, 2021, after market close.

What time is Intricon's conference call scheduled?

Intricon's conference call is scheduled for February 25, 2021, at 4:00 p.m. CT/5:00 p.m. ET.

How can I listen to Intricon's conference call?

Investors can listen to Intricon's conference call by dialing (866) 795-7248 for domestic callers or (470) 495-9160 for international callers, using conference ID: 5468087.

Is there a webcast available for Intricon's conference call?

Yes, a live and archived webcast of Intricon's conference call will be available on the company's website in the 'Investors' section.

IIN

NASDAQ:IIN

IIN Rankings

IIN Latest News

IIN Stock Data

225.49M
7.91M
8.46%
63.11%
1.4%
Medical Instruments & Supplies
Healthcare
Link
United States
Arden Hills